Actively Recruiting

Phase 1
Age: 18Years - 45Years
All Genders
Healthy Volunteers
NCT06716151

A Study to Evaluate HB0034 in Healthy Chinese Adult Participants

Led by Shanghai Huaota Biopharmaceutical Co., Ltd. · Updated on 2025-01-20

60

Participants Needed

1

Research Sites

49 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of this study is to investigate the safety and tolerability of HB0034 in healthy subjects following a single dose or multiple dose.

CONDITIONS

Official Title

A Study to Evaluate HB0034 in Healthy Chinese Adult Participants

Who Can Participate

Age: 18Years - 45Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy male or female subjects age �3E= 18 and �3C= 55 years
  • Body Mass Index (BMI) �3E= 17.5 and �3C= 32 kg/m�B2
  • Normal ECG, blood pressure, respiratory rate, temperature, and heart rate unless considered clinically insignificant by the investigator
  • Signed and dated informed consent prior to study admission in accordance with GCP and local laws
Not Eligible

You will not qualify if you...

  • History of significant cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematological, psychiatric, or neurological disease
  • Current or past malignancy
  • Family history of premature Coronary Heart Disease (CHD)
  • History of significant opportunistic infections such as invasive candidiasis or pneumocystis pneumonia
  • Pregnant or breastfeeding women or those with a positive pregnancy test
  • Additional exclusion criteria apply

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Central Hospital affiliated to Shandong First Medical University

Jinan, Shandong, China

Actively Recruiting

Loading map...

Research Team

Y

Yuan Tang

CONTACT

Q

Qiaoxia Qian

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

8

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here